BMP-2 and TGF-β1 mediate biglycan-induced pro-osteogenic reprogramming in aortic valve interstitial cells

[1]  Y. Bossé,et al.  Inflammation Is Associated with the Remodeling of Calcific Aortic Valve Disease , 2012, Inflammation.

[2]  Weikai Zhang,et al.  Glycosaminoglycan chains of biglycan promote bone morphogenetic protein-4-induced osteoblast differentiation. , 2012, International journal of molecular medicine.

[3]  J. Cleveland,et al.  Biglycan Induces the Expression of Osteogenic Factors in Human Aortic Valve Interstitial Cells via Toll-Like Receptor-2 , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[4]  J. Cleveland,et al.  Cross-Talk Between the Toll-Like Receptor 4 and Notch1 Pathways Augments the Inflammatory Response in the Interstitial Cells of Stenotic Human Aortic Valves , 2012, Circulation.

[5]  C. García-Rodríguez,et al.  Viral and bacterial patterns induce TLR-mediated sustained inflammation and calcification in aortic valve interstitial cells. , 2012, International journal of cardiology.

[6]  A. James,et al.  NELL-1 increases pre-osteoblast mineralization using both phosphate transporter Pit1 and Pit2. , 2012, Biochemical and biophysical research communications.

[7]  H. Papadaki,et al.  Pathophysiologic mechanisms of calcific aortic stenosis , 2012, Therapeutic advances in cardiovascular disease.

[8]  C. Deng,et al.  TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation , 2012, International journal of biological sciences.

[9]  K. J. Grande-Allen,et al.  Differential proteoglycan and hyaluronan distribution in calcified aortic valves. , 2011, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[10]  K. J. Grande-Allen,et al.  Calcific Aortic Valve Disease : Not Simply a Degenerative Process A Review and Agenda for Research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group , 2012 .

[11]  R. O’Keefe,et al.  BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development , 2011, Journal of Cell Science.

[12]  S. Motomura,et al.  Tumor Necrosis Factor-α Accelerates the Calcification of Human Aortic Valve Interstitial Cells Obtained from Patients with Calcific Aortic Valve Stenosis via the BMP2-Dlx5 Pathway , 2011, Journal of Pharmacology and Experimental Therapeutics.

[13]  R. Hinton,et al.  Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves. , 2011, Journal of molecular and cellular cardiology.

[14]  S. Stringer,et al.  Decorin GAG Synthesis and TGF-&bgr; Signaling Mediate Ox-LDL–Induced Mineralization of Human Vascular Smooth Muscle Cells , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Lian-tang Wang,et al.  Endogenous toll-like receptor ligands and their biological significance , 2010, Journal of cellular and molecular medicine.

[16]  Y. Bossé,et al.  Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via Toll-like receptor 2. , 2010, The American journal of pathology.

[17]  C. Erridge.  Endogenous ligands of TLR2 and TLR4: agonists or assistants? , 2010, Journal of leukocyte biology.

[18]  F. Mohr,et al.  Mechanical strain and the aortic valve: influence on fibroblasts, extracellular matrix, and potential stenosis. , 2009, The Annals of thoracic surgery.

[19]  Xiaoping Yang,et al.  Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2. , 2009, The Journal of thoracic and cardiovascular surgery.

[20]  A. Kulkarni,et al.  Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development. , 2009, Developmental biology.

[21]  J. Pfeilschifter,et al.  Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors* , 2009, The Journal of Biological Chemistry.

[22]  J. Cleveland,et al.  Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70. , 2009, American journal of physiology. Heart and circulatory physiology.

[23]  J. Waltenberger,et al.  Molecular and cellular mechanisms of aortic stenosis. , 2009, International journal of cardiology.

[24]  Craig A Simmons,et al.  Calcification by Valve Interstitial Cells Is Regulated by the Stiffness of the Extracellular Matrix , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[25]  S. Young,et al.  Lowering Plasma Cholesterol Levels Halts Progression of Aortic Valve Disease in Mice , 2009, Circulation.

[26]  J. Cleveland,et al.  Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. , 2009, Journal of the American College of Cardiology.

[27]  Kristi S Anseth,et al.  Substrate properties influence calcification in valvular interstitial cell culture. , 2008, The Journal of heart valve disease.

[28]  P. Kovanen,et al.  Complement system is activated in stenotic aortic valves. , 2008, Atherosclerosis.

[29]  J. Cleveland,et al.  Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis. , 2008, American journal of physiology. Cell physiology.

[30]  Yosuke Osawa,et al.  TLR4 enhances TGF-β signaling and hepatic fibrosis , 2007, Nature Medicine.

[31]  R. Levy,et al.  Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. , 2007, The Annals of thoracic surgery.

[32]  H. Jakubowski,et al.  Letter by Undas and Jakubowski regarding article, "Relationship between homocysteine and mortality in chronic kidney disease". , 2006, Circulation.

[33]  M. Amrani,et al.  Role of Human Valve Interstitial Cells in Valve Calcification and Their Response to Atorvastatin , 2006, Circulation.

[34]  S. Hagl,et al.  Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification. , 2005, International journal of molecular medicine.

[35]  Marian F Young,et al.  The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. , 2005, The Journal of clinical investigation.

[36]  K. Hruska,et al.  Bone Morphogenetic Proteins in Vascular Calcification , 2005, Circulation research.

[37]  F. Dagenais,et al.  Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. , 2005, The Journal of heart valve disease.

[38]  M. Young,et al.  The small leucine‐rich proteoglycan biglycan modulates BMP‐4‐induced osteoblast differentiation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  S. Hagl,et al.  Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. , 2003, Atherosclerosis.

[40]  C. Heldin,et al.  Smad regulation in TGF-beta signal transduction. , 2001, Journal of cell science.

[41]  Emile R. Mohler,et al.  Bone Formation and Inflammation in Cardiac Valves , 2001, Circulation.

[42]  R. Harland,et al.  Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Y. Jin,et al.  Induction of new bone by ceramic bovine bone with recombinant human bone morphogenetic protein 2 and transforming growth factor beta. , 1998, International journal of oral and maxillofacial surgery.

[44]  E. Ruoslahti,et al.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.

[45]  K. Watson,et al.  TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. , 1994, The Journal of clinical investigation.